Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 9/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.49 |
| ▸ | CDK1 | P06493 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rosoxacin SCHEMBL29361483 | 1.00 | CAPN1 (0.61) | CAPN1KDM4EHPGDALDH1A1HSD17B10 | |
| SCHEMBL10475298 | 0.91 | CAPN1 (0.59) | CAPN1KDM4EHPGDALDH1A1HSD17B10 | |
| SCHEMBL11655148 | 0.90 | CAPN1 (0.50) | CAPN1KDM4EHPGDALDH1A1HSD17B10 | |
| SCHEMBL10474600 | 0.89 | CAPN1 (0.62) | CAPN1ROCK2CDK1PRKACACDK2 | |
| SCHEMBL10475306 | 0.89 | CAPN1 (0.57) | CAPN1ROCK2CDK1PRKACACDK2 | |
| SCHEMBL10475297 | 0.88 | CAPN1 (0.56) | CAPN1 | |
| SCHEMBL11621910 | 0.87 | LMNA (0.54) | CAPN1KDM4EHPGDALDH1A1HSD17B10 | |
| SCHEMBL11620699 | 0.87 | CAPN1 (0.58) | CAPN1LMNAMEN1ABCC4PKM | |
| SCHEMBL10475303 | 0.87 | ROCK2 (0.63) | CAPN1MEN1KMT2AROCK2CDK1 | |
| SCHEMBL10474604 | 0.87 | ROCK2 (0.52) | CAPN1KDM4EROCK2CDK1PRKACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4545 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4571306-A1 | STABILIZING OXYGEN IN A COMPOSITION | Instrumentation Laboratory Company (US) | 2025-06-18 | — | — | EP | claimed |
| CN-120142412-A | Stabilizing oxygen in a composition | 仪器实验室公司 | 2025-06-13 | — | — | CN | claimed |
| US-20250189479-A1 | STABILIZING OXYGEN IN A COMPOSITION | INSTRUMENTATION LABORATORY COMPANY | 2025-06-12 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-4554939-A1 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | Astrazeneca AB (SE) | 2025-05-21 | — | — | EP | claimed |
| EP-4554627-A1 | INHALABLE FORMULATION FOR USE IN THE TREATMENT OF BACTERIAL LUNG INFECTIONS | Solmic Biotech GmbH (DE) | 2025-05-21 | — | — | EP | claimed |
| US-20250144088-A1 | INHALABLE FORMULATION FOR USE IN THE TREATMENT OF BACTERIAL LUNG INFECTIONS | Solmic Biotech GmbH (DE) | 2025-05-08 | — | — | US | claimed |
| WO-2025080590-A1 | CO-CRYSTALLIZATION OF ACTIVES WITH SACCHARIDE-BASED MOLECULAR FRAMEWORKS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-04-17 | — | — | WO | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20250115942-A1 | SCREENING METHOD FOR ANTI-PSEUDOMONAL AGENTS AND COMPOSITIONS AND METHODS FOR TREATING PSEUDOMONAS INFECTIONS | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGES | 2025-04-10 | — | — | US | claimed |
| EP-0741570-A1 | METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS | G.D. SEARLE & CO. (US) | 1996-11-13 | — | — | EP | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1995020387-A1 | METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS | G.D. SEARLE & CO. (US) | 1995-08-03 | — | — | WO | claimed |
| WO-1991009616-A1 | QUINOLONE ANTIBIOTICS ENCAPSULATED IN LIPID VESICLES | YALE UNIVERSITY (US) | 1991-07-11 | — | — | WO | claimed |
| US-4853225-A | Process for implanting a medicament depot | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-08-01 | — | — | US | claimed |
| EP-0222814-A1 | USE OF QUINOLONE DERIVATIVES FOR THE TREATMENT OF MYCOPLASMAL PNEUMONIA IN PIGS | BEECHAM GROUP PLC (GB) | 1987-05-27 | — | — | EP | claimed |
| WO-1986006630-A1 | USE OF QUINOLONE DERIVATIVES FOR THE TREATMENT OF MYCOPLASMAL PNEUMONIA IN PIGS | BEECHAM GROUP P.L.C. (GB) | 1986-11-20 | — | — | WO | claimed |
| EP-0098577-A2 | Drugs for treating diarrhea caused by infection | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-01-18 | — | — | EP | claimed |